IMC - Annc reads well. Looking forward to Q4.
NASH Phase II Interim Analysis Reveals Improvement in Liver Enzymes (AST and ALT) with Good Safety and Tolerability DSMB Recommends Trial to Continue to Completion
- Forums
- ASX - Day Trading
- Morning Traders 10 July
Morning Traders 10 July, page-4
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online